Principles for diagnosis and treatment of pulmonary embolism
Pulmonary embolism takes the third place in cardiovascular mortality structure. Separate clinical symptoms don’t have adequate sensibility and specificity for pulmonary embolism verification. For pulmonary embolism diagnosis are usually used clinical probability scales. Clinical markers, pulmonic ventricle dysfunction markers, and myocardial injury markers determine risk stratification. Methods for diagnosis and treatment of pulmonary embolism are based on risk levels. In case of suspected pulmonary embolism the treatment should be prescribed immediately without waiting for diagnosis approval. Pulmonary embolism accompanied with shock and hypotension is an absolute thrombolytic therapy indication. According to data, provided by authors, efficacy and safety of prourokinase appeared to be as effective and safe as alteplase according to clinical and instrumental criteria. Alteplase effectiveness is higher than prourokinase in case of short anamnesis (3 days) proukinase has the advantage of alteplase. To prevent repeated venous thromboembolism should be prescribed indirect anticoagulant (Vitamin K antagonist) or factor Xa inhibitor oral inticoagulant rivaroxaban.